From Awareness to Authority: How Patients Shaped Precision Medicine
Breast Cancer Awareness Month has evolved far beyond a public-health campaign. Over four decades, patient advocacy, philanthr [...]
Investment Reports Andre Esteva Interview
Artera is a precision medicine company developing artificial intelligence tools to support personalized cancer treatment deci [...]
Is Your Pathology AI Really Ready?
AI is advancing rapidly in pathology, with new FDA clearances, reimbursement pathways, and growing adoption across health sys [...]
A Faster Path to Breast Cancer Prognosis
An FDA-cleared AI tool offers shorter turnaround times and supports precision oncology Chemotherapy decision-making in early- [...]
AI Finds New Applications in Oncologic Surgery, Drug and Biomarker Screening, and Clinical Trial Design
AI is rapidly moving beyond the realm of future promise and into everyday oncology practice. From enhancing surgical precisio [...]
High-Tech Healthcare in NJ – Medical treatments advance as hospitals implement groundbreaking technologies
New Jersey hospitals have long been on the cutting edge of medical technology in areas ranging from cancer treatments and car [...]
Tempus and Artera Collaborate to Expand Access to New Prognostic Test for Prostate Cancer
Tempus and Artera Collaborate to Expand Access to New Prognostic Test for Prostate Cancer
ASCO 2026: The biggest trends for marketers to watch
Pharma brands are expected to have a large presence in the booths at ASCO this year. Here are the biggest themes marketers sh [...]
FDA approves first AI test to guide breast cancer chemotherapy decisions
As of 2022, there were about 2.3 millionTrusted Source women around the world newly diagnosed with breast cancer, and about 6 [...]